OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
OncoDaily
Jul 1, 2024, 15:04 |
Blog
2024 class of Early Career Researcher recipients - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy made the following post on X: "PICI is thrilled to award…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
Jul 1, 2024, 15:00 |
Blog
Razelle Kurzrock: Universal germline and somatic genomic testing is the key for cancer!
Razelle Kurzrock, Chair of Precision Oncology at MCW Cancer Center, shared a post on X:…
Jul 1, 2024, 14:57 |
Blog
Jose Ramon Flores Valdes: Insights about being a Clinical Research Coordinator of Oncology trials
Jose Ramon Flores Valdes, International Medical Graduate from Autonomous University of Guadalajara, posted on LinkedIn:…
Jul 1, 2024, 14:49 |
Blog
Understanding the role of the FDA will be instrumental in my future trial work and design - Matthew Hadfield
American Association for Cancer Research (AACR) shared a post on X: . “'Understanding the role…
Jul 1, 2024, 14:48 |
Blog
Daniel Castellano: Great proposals in a urothelial cancer workshop at GUARD Symposium 2024
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X: “Great discussion and…
Jul 1, 2024, 14:44 |
Blog
Janine Austin Clayton: NOSI for female-specific health conditions research
Janine Austin Clayton, Associate Director for Research on Women’s Health at NIH, shared a post…
Jul 1, 2024, 14:42 |
Blog
Estela Rodriguez: Proud to be part of the American Cancer Society South Florida volunteer board
Estela Rodriguez shared a post on X: “Proud to be part of the American Cancer…
Jul 1, 2024, 14:36 |
Insight
Intratumoral immune triads in elimination of solid tumors
Patrick Hwu shared on X: "CD8+ 'killer' T cells can eliminate tumor cells. However, they…
Jul 1, 2024, 14:31 |
Blog
Zainab Shinkafi-Bagudu: National Workshop on Population-based Cancer Registration in Nigeria
Zainab Shinkafi-Bagudu shared a post on LinkedIn: “Data is the cornerstone of effective health interventions. In…
Jul 1, 2024, 14:23 |
Blog
Jia Liu: Ensuring sponsors enrol patients on trials with diversity in sex, age, ethnicity and race
Jia Liu, Translational Researcher at The Kinghorn Cancer Centre, shared a post by FDA on…
Jul 1, 2024, 14:22 |
Insight
Ponatinib CSF concentrations in Ph+ ALL
Anand Patel shared on X: "Very informative paper in Blood Journal looking at ponatinib CSF concentrations…
Jul 1, 2024, 14:13 |
Blog
UICC acknowledges the invaluable support of over 50 strategic partners
Union for International Cancer Control shared on LinkedIn: "UICC proudly acknowledges the invaluable support of…
Jul 1, 2024, 14:10 |
Career
Wafik S. El-Deiry: I am pleased to join Oncotarget as an Editor-in-Chief
Wafik S. El-Deiry shared on LinkedIn: "I am pleased to join Oncotarget as an Editor-in-Chief…
Jul 1, 2024, 14:04 |
Blog
Khaled Ghanem: The second Damascus Stem Cells Meeting
Khaled Ghanem shared on X: "Kicking-off the second Damascus Stem Cells Meeting with a 34 educational…
Jul 1, 2024, 14:03 |
Drugs
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Significant advancements in NSCLC treatment! SCRI's Dr. Robert Jotte…
Jul 1, 2024, 13:53 |
Drugs
Todd Davis: Approval of Verona Pharma’s Ohtuvayre
Todd Davis, CEO at Ligand Pharmaceuticals, shared on LinkedIn: "When I stepped in as CEO…
Jul 1, 2024, 13:46 |
Blog
The July issue of Annals of Oncology
Annals of Oncology shared a post on LinkedIn: “New online - the July issue of…
Jul 1, 2024, 13:39 |
Blog
Mohamad Mohty: Comprehensive review of Multiple Myeloma published in Nature Reviews Disease Primers
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Jul 1, 2024, 13:38 |
Blog
Bill Wood: Honored to participate in the White House Clinical Trials Forum
Bill Wood, Professor of Medicine with tenure in Division of Hematology at University of North…
Jul 1, 2024, 13:35 |
Blog
Research Grants and Fellowship Program researcher gathering in Boston - Prevent Cancer Foundation
Prevent Cancer Foundation made the following post on LinkedIn: "Yesterday was our Research Grants and…
Jul 1, 2024, 13:29 |
Blog
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University…
Jul 1, 2024, 13:26 |
Blog
Bente Mikkelsen: SIDS Action for NCDs and Mental Health
Bente Mikkelsen shared a post on LinkedIn: . "I am pleased to share the second…
Jul 1, 2024, 13:17 |
Blog
Luis E. Raez Discussed Lung Cancer Screening Programs with the American Lung Association
Luis E. Raez, Co-Director of MCI/FAU Florida Cancer Center of Excellence, shared on LinkedIn: “Discussing…
Jul 1, 2024, 13:14 |
Blog
Francis Makokha: Profiling neoantigens expressed in Kenyan breast cancer patients
Francis Makokha, Head of Human Health Research Programme at Mount Kenya University, shared on X: "Another…
Jul 1, 2024, 12:54 |
Dialogues
ASCO24 Updates: Improving Cancer Care in Nigeria: HE Zainab Shinkafi-Bagudu
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 1, 2024, 12:51 |
Blog
Career Development Beyond the FDA-AACR Oncology Educational Fellowship
FDA Oncology posted on X: "Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship…
Jul 1, 2024, 12:42 |
Blog
It’s about making sure we are supporting our nurses from every angle - Atrium Health
Atrium Health made the following post on LinkedIn: "'This is a BIG DEAL!' Advocate Health…
Jul 1, 2024, 12:39 |
Blog
Percy Lee: Sharing esoteric stories, future of oncology, history of City of Hope
Percy Lee posted on X: "Night cap with Jake Scott, Russell Rockne, Yun Rose Li sharing…
Jul 1, 2024, 12:34 |
Blog
Ilaria Colombo: New targets and new drugs for the treatment of ovarian cancer at XXI MaNGO meeting
Ilaria Colombo, Medical Oncologist at MD. Drug Development and Gyne Cancer, posted on X: "Great…
Jul 1, 2024, 12:25 |
Blog
Allison Institute announced appointment of two immunobiology experts as associate members
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center announced the appointment…
Jul 1, 2024, 12:24 |
Blog
Arya Roy: Upstate from ASCO24 NY Cancer Symposium HER2+ Breast Cancer data
Arya Roy posted on X: "Great start for Upstate NY Cancer Symposium by Susan Dent…
Jul 1, 2024, 12:12 |
Blog
Advancing Diversity, Equity, and Inclusion in the Cancer Workforce - NCCN
National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn: . "Join us in Washington,…
Jul 1, 2024, 12:11 |
Insight
Myeloma Paper of the Day, July 1st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: A two-sample Mendelian randomization study…
Jul 1, 2024, 12:09 |
Insight
Nicole Kuderer: Glad we finally realize that pCR is not a valid trial surrogate for OS/DFS
Nicole Kuderer, medical oncologist at the Division of Hematology of the University of Washington Medical…
Jul 1, 2024, 12:07 |
Blog
Dégi László Csaba: Andras Kulja is a supporter of completing, refreshing, and expanding Europe's Beating Cancer Plan
Dégi László Csaba, President at European Cancer Organisation, shared on LinkedIn: "I welcomed Andras Kulja, MEP,…
Jul 1, 2024, 12:00 |
Blog
Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter: "Congrats Neeraj Agarwal on yet another stellar achievement! And for…
Jul 1, 2024, 11:57 |
Insight
START Midwest team has successfully dosed the first patient in the first QTX3046 Phase I trial
The START Center for Cancer Research shared on LinkedIn: "We are proud to announce that…
Jul 1, 2024, 11:55 |
Blog
Mark Lewis: Things to discuss at the patient's first visit
Mark Lewis shared a post by Suneel Dhand, Physician in Internal Medicine, on X, adding the…
Jul 1, 2024, 11:45 |
Blog
Susanna F. Greer: Fifteen Women scientists awarded more than 10M in research grants from the V Foundation
Susanna F. Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared a…
Jul 1, 2024, 11:44 |
Blog
Shikha Jain: Seeking Sponsors for the 2024 Women in Medicine Summit!
Shikha Jain shared on LinkedIn: "Seeking Sponsors for the 2024 Women in Medicine Summit! We…
Jul 1, 2024, 11:19 |
Blog
Douglas Flora: No Cancer Patient Should Go Hungry
Douglas Flora shared a post on LinkedIn: “No Cancer Patient Should Go Hungry! The cancer team…
Jul 1, 2024, 10:01 |
Blog
Stephen Chun: Long-term outcomes of IMRT for locally-advanced lung cancer
Stephen Chun made the following post on X: “Happy to report long-term outcomes of intensity modulated…
Jul 1, 2024, 09:25 |
Insight
Sylvester cancer expert endorses FDA approval of new drug
The drug, imetelstat, provides a new option for patients suffering from anemia from their cancer.…
Jul 1, 2024, 09:17 |
Blog
Medigene Reports Results of Annual General Meeting
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jul 1, 2024, 09:12 |
Blog
Agenus - CTEP has announced the availability of botensilimab for clinical studies
Agenus shared on LinkedIn: “The National Cancer Institute (NCI)'s Cancer Therapy Evaluation Program (CTEP) has…
Jul 1, 2024, 08:21 |
Blog
Karen Knudsen: MCEDAct creates a pathway to ensure timely Medicare coverage
Karen Knudsen shared a post by American Cancer Society Cancer Action Network, on X: "In 2024, over 1…
Jul 1, 2024, 08:08 |
Blog
CtDNA in early Colorectal cancer
Vittorio Studiale, Medical Oncology resident at Pisan hospital-university, shared on X: "CtDNA in early CRC >…
Jul 1, 2024, 07:57 |
Blog
Raffaele Colombo: TOPO1i ADC after TOPO1i ADC?
Raffaele Colombo shared on X: "TOPO1i ADC after TOPO1i ADC? ADC-LOW: a French, multicentric, retrospective study…
Jul 1, 2024, 07:31 |
Insight
Dan Vahdat: Digital-first cancer care for all
Dan Vahdat, CEO and Founder of Huma, shared a post by Macmillan Cancer Support, on…
Jul 1, 2024, 06:50 |
Blog
Am I Doing Enough? - Pat Garcia-Gonzalez
The Max Foundation shared on LinkedIn: “‘Birthdays are a time to take stock on our…
Jul 1, 2024, 06:22 |
Insight
Partnership with Novartis for over 20 years - The Max Foundation
The Max Foundation shared on LinkedIn: “Thanks to Vas Narasimhan, for recognizing our impactful collaboration.…
Jul 1, 2024, 06:11 |
Insight
Conquer Cancer has awarded more than $11 million to physician-scientists at the ASCO Annual Meeting
Conquer Cancer, the ASCO Foundation shared on LinkedIn: “We're proud to have awarded more than…
Jul 1, 2024, 06:09 |
Drugs
FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma - Genmab
Genmab shared a post on LinkedIn: “Breaking News: The FDA has approved our medicine for…
Jul 1, 2024, 05:52 |
Insight
The final showcase event of PROTECT-EUROPE and SmartCARE - ECO
European Cancer Organisation (ECO) shared on LinkedIn: “Join us on 22 November for the final…
Jul 1, 2024, 05:46 |
Cancer Types
Endometrioid Adenocarcinoma: What patients should know about
What is Endometrioid Adenocarcinoma? Endometrioid adenocarcinoma is a type of cancer that originates in the…
Jul 1, 2024, 05:32 |
Insight
Douglas Flora: AI for mental health and patient support
Douglas Flora shared a post on LinkedIn: “AI for mental health and patient support?! Yes! Mika…
Jul 1, 2024, 03:19 |
Blog
Shahrin Ahmed: MED12 is identified as being instrumental in basal-like pancreatic cancer
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "Pancreatic cancer awareness…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jul 1, 2024, 02:54 |
Blog
Erman Akkus: Take home messages from Proffered Papers session at ESMOGI24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Take home…
Jul 1, 2024, 02:31 |
Blog
Biagio Ricciuti receives a 2024 IASLC YIA to develop new therapies for KRAS amplified NSCLC
Biagio Ricciuti shared a post by Dana-Farber News, on X: "Thrilled to receive a 2024…
Jul 1, 2024, 02:27 |
Blog
Krishna Komanduri: Big deal and a win for immunotherapy patients
Krishna Komanduri, Physician in Chief at UCSF Helen Diller Family Comprehensive Cancer Center, made the following post…
Jul 1, 2024, 02:25 |
Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jul 1, 2024, 02:17 |
Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:16 |
Blog
Chadi Nabhan: A major collaboration BTW Healthcare Unfiltered and Vivek Subbiah
Chadi Nabhan, Medical Director of The University of Chicago Medical Center, shared on X: “Announcing…
Jul 1, 2024, 01:56 |
Blog
Richard Scolyer: The Melanoma Institute Australia team remains committed to reach zero deaths from melanoma
Richard Scolyer shared a post on X: "The Melanoma Institute Australia team had a very…
Jul 1, 2024, 01:48 |
Blog
Sarah P. Psutka: Last day in the OR together
Sarah P. Psutka, Associate Editor at European Urology, shared a post by Betsy Koehne, Urologic Oncology…
Jul 1, 2024, 01:42 |
Blog
Robin Zon: So excited for the year ahead in ASCO
Robin Zon shared on X: . "Thank you ASCO leadership and…
Jul 1, 2024, 01:36 |
Insight
Challenges in delivering radiotherapy to lymph nodes in rectal cancer
Nina Niu Sanford shared a post by Ane Appelt, Associate Professor at the University of…
Jul 1, 2024, 01:24 |
Blog
Daniel Castellano: Biomarker selected bladder sparing preservation program is the future
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X: "Excellent and clarifier…
Jul 1, 2024, 01:05 |
Blog
Mark Lewis: It’s about the clones
Mark Lewis shared a post on X: "To the person sitting next to me on…
Jul 1, 2024, 00:53 |
Insight
Ishwaria Subbiah: Quick read from Daniel Goleman - A Boost DEI Might Need
Ishwaria Subbiah shared on LinkedIn: "Clearing the space this afternoon with this quick read from…
Jul 1, 2024, 00:19 |
Blog
Late Effects After High-Risk Neuroblastoma - St. Baldrick's Foundation
St. Baldrick's Foundation shared on LinkedIn: "Modern therapies (such as stem cell transplant and immune…
Jun 30, 2024, 16:30 |
Insight
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn: “Patients with stage…
Jun 30, 2024, 16:23 |
Blog
Meet Kayinfa Nicole E., Program Coordinator in Mozambique - The Max Foundation
J. Michael Wrigglesworth, Vice President of Programs Operations at The Max Foundation shared a post…
Jun 30, 2024, 16:16 |
Blog
Gianluca Giannarini: Great joint ESUI - EAU Section Urological Imaging session
Gianluca Giannarini, Associate Editor of European Urology, Full Board Member of the EAU Guidelines Office, shared…
Jun 30, 2024, 16:13 |
Blog
Gonzalo Fernández-Miranda: Incredible 5 days at the Neurofibromatosis 2024 Global NF Conference
Gonzalo Fernández-Miranda, Founder in Residence at Deep Science Ventures, shared a post on LinkedIn: "What…
Jun 30, 2024, 16:06 |
Positive
Trish Boh: 400th stage I lung cancer patient through pioneering screening program
Trish Boh, Executive Secretary to the Executive Medical Director of Oncology Services and Directors at…
Jun 30, 2024, 15:52 |
Societies
ESO is collecting story proposals for the 2nd edition of their writing contest
Corinne Hall, Manager at the European School of Oncology (ESO), shared a post by ESO…
Jun 30, 2024, 15:45 |
Career
William Kaelin was recognized with the Stanley P. Reimann Honor Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "William Kaelin Jr., MD, physician, scientist, and Nobel laureate, was…
Jun 30, 2024, 15:35 |
Blog
Gerrey Family and Shine Like Charli hosted their 3rd annual Shine Like Charli Gala Ball
Children's Cancer Institute shared on LinkedIn: "Since Charli was diagnosed with Leukaemia in 2020 at…
Jun 30, 2024, 15:28 |
Positive
The V Foundation's new class of Grant of Her Own initiative
The V Foundation shared on LinkedIn: "We are thrilled to announce our new class of…
Jun 30, 2024, 15:19 |
Blog
Elina Bashratyan: I have completed the "Medical Excellence in Modern Oncology" course
Elina Bashratyan, Medical Student at Yerevan State Medical University, shared on LinkedIn: "I am excited to…
Jun 30, 2024, 15:14 |
Blog
Ruben Mesa: Join us at South Piedmont AHEC for the MPN Workshop of the Carolinas
South Piedmont Area Health Education Center posted on LinkedIn: "Join South Piedmont Area Health Education…
Jun 30, 2024, 15:08 |
Blog
Sami Mansfield: Challenges in implementing exercise oncology and cancer rehabilitation
Sami Mansfield posted on LinkedIn: "Almost every day, I hear from my oncology colleagues that…
Jun 30, 2024, 15:04 |
Blog
Bria Carrithers: From 1st day of intern year to the last day of residency
Bria Carrithers, Graduate Student at Hampton University, shared, on X: "From 1st day of intern year…
Jun 30, 2024, 14:56 |
Blog
Sachin Jain: An abnormal behavior that is normalized is idea theft
Sachin Jain posted on LinkedIn: "An abnormal behavior that is normalized in many organizations is…
Jun 30, 2024, 14:53 |
Blog
Nirmala Bhoo Pathy: More students are welcome for Master of Epidemiology Program
Nirmala Bhoo Pathy shared a post by Public Health at University of Malaya, on LinkedIn, adding: “Leading…
Jun 30, 2024, 14:51 |
Insight
Sergio Cifuentes: Phase 2 study on neoadjuvant nivolumab + ipilimumab in dMMR colon cancer
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X about…
Jun 30, 2024, 14:47 |
Blog
One event to celebrate two impressive projects - European Cancer Organisation
European Cancer Organisation (ECO) shared a post on X: . "One event to celebrate two…
Jun 30, 2024, 14:45 |
Blog
Florian Scotté: MASCC has a new board of Directors for the two years term
Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted…
Jun 30, 2024, 14:29 |
Societies
22 Posts You Should Not Miss From MASCC24!
The Multinational Association of Supportive Care in Cancer (MASCC) had its Annual Meeting this year…
Jun 30, 2024, 14:21 |
Blog
Rob Winn: That’s a wrap for the AACI Clinical Research Innovation Meeting
Rob Winn shared on X: . "That’s a wrap for the…
Jun 30, 2024, 14:19 |
Blog
MSN Laboratories - Our new division, Radium - Rare Diseases And Unmet Needs
MSN Laboratories shared on LinkedIn: "We are excited to launch a New Division!. Patients with rare…
Jun 30, 2024, 14:19 |
Insight
Reprogramming Tumor-Associated Macrophages with Glutamine Antagonist JHU083
Maria Babak shared a post by The Babak Lab on LinkedIn: "Absolutely thrilled to see…
Jun 30, 2024, 14:18 |
Blog
Vincent Rajkumar's 2024 AJH update on diagnosis and treatment of myeloma will be out soon
Vincent Rajkumar shared a post on X: . "My 2024…
Jun 30, 2024, 14:10 |
Blog
Mental, social, and financial challenges faced by Young Adults with Lung cancer - Florez Lab
Florez Lab shared a post on X: , "Rising lung cancer…
Jun 30, 2024, 14:10 |
Blog
SIOP Europe Course in Paediatric Oncology applications are now open
SIOP Europe shared on X: "Did you hear the great news? The applications for the…
Jun 30, 2024, 14:04 |
Blog
Translating Omics to Diagnostic Tests: New course available by EHA
European Hematology Association (EHA) shared a post on X: . "New course available: Myeloid…
Jun 30, 2024, 14:00 |
Blog
UroToday.com - Exploring imaging options and impact to treatment strategies in nmCPRC
UroToday.com shared on X: "Navigating the Nuances: Exploring imaging options and impact to treatment strategies in…
24
25
26
27
28
All:
15718
Posts:
2501 - 2600
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube